Most Popular
![[Exclusive] Hyundai Mobis eyes closer ties with BYD](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/11/25/20241125050044_0.jpg&u=)
-
6
[Herald Review] 'Gangnam B-Side' combines social realism with masterful suspense, performance
![[Herald Review] 'Gangnam B-Side' combines social realism with masterful suspense, performance](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/11/25/20241125050072_0.jpg&u=)
-
7
Jung's paternity reveal exposes where Korea stands on extramarital babies
-
8
Why S. Korean refiners are reluctant to import US oil despite Trump’s energy push
-
9
Agency says Jung Woo-sung unsure on awards attendance after lovechild revelations
-
10
Prosecutors seek 5-year prison term for Samsung chief in merger retrial
![[Herald Review] 'Gangnam B-Side' combines social realism with masterful suspense, performance](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/11/25/20241125050072_0.jpg&u=)
SK Biopharm, Hanmi sign deal to sell epilepsy drug
By Korea HeraldPublished : April 22, 2012 - 21:09
SK Biopharmaceuticals Co. said Sunday it established a strategic partnership with Hanmi Pharm Co. to sell a nasal spray-type epilepsy drug in Korea and China.
Hanmi and its Chinese arm will get the approval for sales and handle marketing in Korea and China, under the partnership.
The diazepam nasal spray quickly transfers the diazepam substance to the brain through the mucous membranes inside the nasal cavity, allowing swift treatment, according to SK Biopharm.
The pharmaceutical company expects to commercialize the drug in Korea next year and in China in 2015.
SK Biopharm plans to file for approval on the new drug sales through its U.S. importer to the U.S. Food and Drug Administration in the first half of this year after completing clinical trials.
(sophie@heraldcorp.com)
Hanmi and its Chinese arm will get the approval for sales and handle marketing in Korea and China, under the partnership.
The diazepam nasal spray quickly transfers the diazepam substance to the brain through the mucous membranes inside the nasal cavity, allowing swift treatment, according to SK Biopharm.
The pharmaceutical company expects to commercialize the drug in Korea next year and in China in 2015.
SK Biopharm plans to file for approval on the new drug sales through its U.S. importer to the U.S. Food and Drug Administration in the first half of this year after completing clinical trials.
(sophie@heraldcorp.com)
-
Articles by Korea Herald
![[Today’s K-pop] BTS’ Jin single hits Billboard’s Hot 100 at No. 53](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=642&simg=/content/image/2024/11/26/20241126050076_0.jpg&u=)